Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin–bilirubin score (ALBS grade)
Kazuya Kariyama, Atsushi Hiraoka, Takashi Kumada, Satoshi Yasuda, Hidenori Toyoda, Kunihiko Tsuji, Takeshi Hatanaka, Satoru Kakizaki, Atsushi Naganuma, Toshifumi Tada, Koichi Takaguchi, Ei Itobayashi, Toru Ishikawa, Noritomo Shimada, Akemi Tsutsui, Takuya Nagano, Michitaka Imai, Shinichiro Nakamura, Akiko Wakuta, Nozomi Miyake, Shohei Shiota, Kazuhiro Nouso
Topics & Concepts
Hepatocellular carcinomaMedicineInternal medicineGastroenterologyAlbuminLenvatinibProportional hazards modelBilirubinGrading (engineering)Hazard ratioSorafenibConfidence intervalCivil engineeringEngineeringHepatocellular Carcinoma Treatment and PrognosisInflammatory Biomarkers in Disease PrognosisLiver Disease Diagnosis and Treatment